Immunodeficiency-related Hodgkin lymphoma and its mimics.
Classic Hodgkin lymphoma (CHL) in patients with underlying immunodeficiency disorders frequently differs from that in the immune competent population in terms of its clinical behavior and pathologic features. Moreover, differential from Hodgkin-like lymphoid proliferations may be problematic. Topics under review include: (a) CHL posttransplant lymphoproliferative disorders, (b) CHL in HIV/AIDS, (c) Hodgkin variant of Richter syndrome in chronic lymphocytic leukemia in association with fludarabine therapy, (d) CHL in other immunodeficiency states including methotrexate-associated lymphoproliferative disorder in patients with rheumatoid arthritis and primary immune deficiencies, and (e) Hodgkin-like lymphoid proliferations including senile Epstein-Barr virus+ B-cell lymphoproliferative disorder. Also under consideration is the pathogenesis of these disorders with an emphasis on the role of Epstein-Barr virus.
Said
Jonathan W
JW
David Geffen School of Medicine at UCLA, Department of Pathology and Laboratory Medicine UCLA Medical Center, Los Angeles, CA 90095, USA. JSaid@mednet.ucla.edu
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications; D020031:Epstein-Barr Virus Infections / Q000150:complications / Q000276:immunology*; D015658:HIV Infections / Q000150:complications; D004854:Herpesvirus 4, Human; D006689:Hodgkin Disease / Q000209:etiology* / Q000276:immunology* / Q000473:pathology*; D006801:Humans; D016867:Immunocompromised Host; D007153:Immunologic Deficiency Syndromes / Q000150:complications*; D016483:Lymphoma, AIDS-Related / Q000276:immunology*; D016377:Organ Transplantation / Q000009:adverse effects